Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy

Front Oncol. 2023 Dec 15:13:1302413. doi: 10.3389/fonc.2023.1302413. eCollection 2023.

¹ Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
² Department of Anatomy and Cell Biology, Cancer and Genetics Research Complex, University of Florida, Gainesville, FL, United States.
³ The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
⁴ Department of Biotechnology and Microbiology, Kannur University, Kannur, India.
⁵ Department of Biotechnology, University of Calicut, Malappuram, India.
⁶ Department of Pathology, Government Medical College, Kottayam, India.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.656804.].

Keywords: 5-FU; breast cancer; chemoresistance; chemosensitization; curcumin; thymidylate synthase.